✦ LIBER ✦

Bronchial reactivity and fractional exhaled NO in Crohn’s disease in the era of immunomodulating treatment

✍ Scribed by Galit Livnat; Aaron Lerner; Fahed Hakim; Orly Eshach-Adiv; Drora Berkowitz; Lea Bentur

Book ID: 114817429
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 107 KB
Volume: 101
Category: Article
ISSN: 0803-5253
DOI: 10.1111/j.1651-2227.2012.02751.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical characteristics of total parent

Clinical characteristics of total parenteral nutrition (TPN) dependent Crohn’s disease (CD) patients in the era of biologic and immunomodulator therapy

✍ Tan Attila; Kristi A. Spinelli; Mary F. Otterson; Attila Nakeeb; Gordon L. Telfo 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 24 KB

P144 INFLIXIMAB IN COMBINATION WITH IMMU

P144 INFLIXIMAB IN COMBINATION WITH IMMUNOMODULATORS IN THE TREATMENT OF CHILDREN WITH CROHN'S DISEASE: ADVANTAGES AND RISKS

✍ A. Prytula; T. Mahler; I. Paquot; P. Alliet; G. Veereman-Wauters 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 68 KB

W1265 Infliximab in Combination with Imm

W1265 Infliximab in Combination with Immunomodulators in the Treatment of Children with Crohn's Disease: Advantages and Risks

✍ Veereman, Gigi; Prytula, Agnieszka; Mahler, Tania; Alliet, Philippe; Paquot, Isa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

P541 Does smoking increase the need for

P541 Does smoking increase the need for the use of immunomodulator treatment in Crohn's disease patients?

✍ Ellul, P.; Saliba, C.; Azzopardi, N.; Grech Margeurat, D.; Laferla, G.; Grech, G 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 49 KB

Infliximab and the risk of latent viruse

Infliximab and the risk of latent viruses reactivation in active Crohn's disease

✍ Alessandro Lavagna; Massimiliano Bergallo; Marco Daperno; Raffaello Sostegni; Cr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Background: Infliximab is used for refractory Crohn's disease but there are concerns regarding long-term safety. Recently, JCpolyomavirus (JCV) was studied after 3 cases of progressive multifocal leukoencephalopathy (PML) were found after treatment with natalizumab. The aim of this study was to

Immune stimulation in Crohn's disease: S

Immune stimulation in Crohn's disease: Safety and efficacy of rhuGM-CSF for the treatment of active Crohn's disease

✍ Korzenik, Joshua R.; Dieckgraete, Brian K. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 372 KB